Multicenter targeted metabolomics and machine learning identify a six-metabolite rheumatoid-arthritis diagnostic panel
Across seven cohorts and five medical centers, targeted metabolomics confirmed six metabolites—imidazoleacetic acid, ergothioneine, N-acetyl-L-methionine, 2-keto-3-deoxy-D-gluconic acid, 1-methylnicotinamide and dehydroepiandrosterone sulfate—as a panel for classifying rheumatoid arthritis against healthy controls and osteoarthritis. LASSO selected the six features, and logistic regression, random forest and XGBoost models were externally evaluated in geographically distinct cohorts; reported AUCs were 0.8375–0.9280 for RA versus healthy controls and 0.7340–0.8181 for RA versus osteoarthritis in three validation cohorts.
Technology: LASSO feature selection and logistic regression, random forest, support vector machine and XGBoost classifiers applied to untargeted and targeted metabolomics
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: Across seven cohorts and five medical centers, targeted metabolomics confirmed six metabolites—imidazoleacetic acid, ergothioneine, N-acetyl-L-methionine, 2-keto-3-deoxy-D-gluconic acid, 1-methylnicotinamide and dehydroepiandrosterone sulfate—as a panel for classifying rheumatoid arthritis against healthy controls and osteoarthritis.
- Still unknown: This is a cross-sectional case–control diagnostic study, not prospective screening or evidence of improved patient outcomes. The authors note that disease activity and treatment effects were not assessed, so prognostic and treatment-monitoring uses are not established. Performance varied across cohorts and was lower for RA-versus-OA than RA-versus-healthy-control classification; stronger platform-specific than sample-type effects were observed. Some mechanistic relevance of the six metabolites remains uncertain.
- AI role: Machine-learning feature selection narrowed targeted-validated metabolites to a six-analyte panel, and supervised classifiers combined the measurements to distinguish RA from healthy controls and osteoarthritis in multiple independent cohorts. Targeted mass spectrometry provided absolute quantification; the models produced the reported cross-cohort diagnostic discrimination.
Evidence sources: https://link.springer.com/article/10.1186/s12967-025-07265-w
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: at percentile 88 of works of the same type, year and subfield (OpenAlex work metrics, 5 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.